Imatinib Completed Phase N/A Trials for Chronic Myeloid Leukemia (CML) / Newly Diagnosed

IndicationsStatusPurposePhase
CompletedNot AvailableNot Available
clinicaltrials.gov IdentifierTitleDrugs
NCT00632255Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment